In a bid to lower prescription drug prices, the Biden administration this week reached an agreement for new, lower prices for the 10 drugs selected for negotiations. These drugs, the White House said, are some of the most expensive and most frequently dispensed drugs in the Medicare program and are used to treat conditions such as heart disease, diabetes and cancer.